MDCaribbeanIndependent school intelligenceFind a school
Explore MDCaribbean
Editorial notice. MDCaribbean is an independent research resource. We use official sources where available and flag gaps in the evidence. Verify important information with the relevant school, regulator or other official authority before making a decision. Read the evidence status.

Decision workspace

Compare Caribbean medical schools

Review three school records on the same evidence grid. Regional programs and historical records have different pathways; compare like with like. Blank or unverified data stays visible—it is not filled with marketing assumptions.

Published tuition is not a complete attendance-cost estimate. Compare academic charges and build an adjustable budget for seven supported schools in the Total Cost Explorer.

Three columns are prefilled for exploration; they are not recommendations or a ranking. Scheduled totals use the reviewed tuition and selected school fees across the published program schedule, without inflation. They are not total costs of attendance. Residency percentages use different cohorts and time periods and cannot be ranked directly.

School 1
School 2
School 3

Scroll sideways to see every school. The row labels stay in view.

Evidence dimension
BIMSBioprist Institute of Medical SciencesFull profile
Ross MedRoss University School of MedicineFull profile
SabaSaba University School of MedicineFull profile
Location
Montego Bay, Jamaica
Bridgetown / St. Michael, Barbados
The Bottom, Saba
Accreditor
CAAM-HP
CAAM-HP
NVAO
Recorded status
CAAM-HP record: Candidacy, 2025–2027.
Accreditor source ↗
CAAM-HP lists Ross as accredited with conditions until the next site visit. CAAM-HP listed September 20–25, 2026 on its visit schedule. Completion and a subsequent determination were not independently confirmed.
Accreditor source ↗
Saba University School of Medicine received NVAO accreditation for its medical programme in 2018, following initial accreditation in 2012. Under the Dutch accreditation framework, existing-programme accreditation does not automatically lapse at the end of a six-year review cycle. Saba continues to report NVAO accreditation. Independent confirmation of its most recent reassessment is pending.
Accreditor source ↗
U.S. and Canadian credential eligibility
WDOMS F0009237 lists an operational English-language MD program beginning instruction in 2024. The accessible Sponsor Notes section did not display an ECFMG graduation-year range or a Canada Sponsor Note in this review. ECFMG states that without its Sponsor Note, students and graduates are not eligible for ECFMG Certification. A WDOMS listing alone does not establish eligibility. Seek direct confirmation from ECFMG and the intended Canadian or other regulator for the exact program and graduation year.
WDOMS F0001354 carries an ECFMG Sponsor Note for graduation years 1979–Current and a Canada Sponsor Note. Individual certification and licensing conditions still apply; recognized-accreditation reporting is a separate check.
WDOMS record F0001887 lists ECFMG Sponsor Note graduation years 1994–Current, conditional on all other requirements, and a Canada Sponsor Note. Recognized-accreditation reporting is separate from individual ECFMG eligibility. The record distinguishes a current M.S. track from an older M.D. track ending in 2014; confirm the final diploma title against ECFMG’s credential guide. Neither listing nor a school claim establishes eligibility for every licensing jurisdiction.
Tuition + selected school fees (USD)
Not calculated in this review
$344,780
$298,750
Model exclusions
See the school's current fee schedule
Other fees, insurance, living costs, travel, exams, interest and repeated terms; see profile for details
Other fees, insurance, living costs, travel, exams, interest and repeated terms; see profile for details
School-published costs
US$173,955 school-quoted tuition and administration, effective Summer 2024; current intake confirmation and other costs required.
School cost source ↗
US$344,780 calculated tuition + administrative model under the published September 2026 11-semester schedule; technology, insurance, living costs and other charges excluded.
School cost source ↗
US$298,750 tuition + administrative fees over 10 terms for September 2026 entrants; the school lists the same numeric CAD amount for eligible Canadian citizens. Additional costs excluded.
School cost source ↗
U.S. federal aid evidence
Not verified in MDCaribbean’s current source set
Federal school list checked in source review; individual and program conditions apply
Federal school list checked in source review; individual and program conditions apply
Clinical model
The school describes an 82-week clinical phase, assigned through its clinical affairs office, with possible sites in the U.S., Jamaica, the wider Caribbean and Asia. Electives can involve individual arrangements. These descriptions do not establish an allocated place, active contract capacity, visa access or licensing eligibility. Obtain a site-by-site schedule and supervising-school confirmation.
Ross describes an 80-week U.S. clinical curriculum: 48 core weeks and 32 elective weeks. It applies to students starting Semester 1 in September 2023 or later and clinical transfers from January 2026. Earlier entrants retain their prior requirements. Site allocation depends on factors including academic performance and capacity; a network listing is not a guaranteed individual placement.
School describes five basic-science terms on Saba, then an eight-week research module and 72 rotation weeks: 42 core and 30 elective. Core training is in the U.S.; Canada offers selected electives. Site availability, waiting times and individual allocations are not independently confirmed.
Residency evidence
No auditable school-specific residency Match rate, first-attempt USMLE cohort series or entering-cohort completion/attrition data were located in the reviewed materials. Statements about preparation and residency support are not measured outcomes. WDOMS records instruction beginning in 2024; do not import results from other schools.
School-reported source ↗
School-reported 96% first-time residency attainment for 2025–26 graduates/expected graduates applying in the 2026 Match or attaining residency outside it. This is not the share of original matriculants who become residents. A separate school list reports 475 positions in 2026 and includes PGY1 and PGY2; the count is not the rate denominator.
School-reported source ↗
School-reported 99% three-year residency placement for 2023–24, 2024–25 and 2025–26 graduates or expected graduates who actively applied through NRMP or obtained residency outside it. This is not an entering-cohort success rate; underlying counts were not provided on the reviewed facts page.
School-reported source ↗
Accreditor record check
2026-11-04
2026-11-06
2026-11-06
Other evidence snapshot date
November 4, 2026 · source review; qualifications remain
November 4, 2026 · source review; see qualifications
November 3, 2026 · claim-level review; gaps remain
Independent read
A Montego Bay MD program in CAAM-HP candidacy for 2025–2027. Candidacy is distinct from provisional or full accreditation. The regulator’s January 2026 update raises governance and assessment concerns; exam eligibility, current fees and mature outcomes need further confirmation.
A Barbados-based MD program with conditional CAAM-HP accreditation, a large U.S. clinical network and published cohort-specific billing. Resolve the post-October-2026 accreditation update, clinical billing and financing before relying on headline outcomes.
A Dutch Caribbean medical programme with documented NVAO accreditation history and a published fee schedule. The most recent NVAO reassessment remains to be independently confirmed.
A lower published tuition is not automatically a lower total cost. Add mandatory fees, housing, travel, insurance, exam costs, financing interest and the cost of any repeated term.